Charles R Harrington

Scopus Author ID Scopus author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Venues

Cells

International journal of molecular sciences

Biomedicines

Brain communications

University of Aberdeen

University of Glasgow (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Aberdeen

United Kingdom

Senior Research Fellow :: Institute of Medical Sciences

University of Cambridge

United Kingdom

Research Fellow :: Cambridge Brain Bank Laboratory

Coralab Research/Murex Medical

United Kingdom

Program Manager :: R&D

University of Cambridge

United Kingdom

Research Assistant :: Biochemistry

University of Kansas Medical Center

United States

Postdoctoral Fellow :: Biochemistry

Education History

University of Glasgow

United Kingdom

PHD :: Microbiology

University of Glasgow

United Kingdom

BSC :: Microbiology

Publications

David Horsley, Janet E Rickard, Thomas Vorley, Matilda F Leeper, Claude M Wischik, Charles R Harrington
Assays for the Screening and Characterization of Tau Aggregation Inhibitors. Methods in molecular biology (Clifton, N.J.) 2754 (2024)
Maciej Zadrozny, Patrycja Drapich, Anna Gasiorowska-Bien, Wiktor Niewiadomski, Charles R Harrington, Claude M Wischik, Gernot Riedel, Grazyna Niewiadomska
Neuroprotection of Cholinergic Neurons with a Tau Aggregation Inhibitor and Rivastigmine in an Alzheimer's-like Tauopathy Mouse Model. Cells 13 (7) (2024)
Maciej Zadrozny, Patrycja Drapich, Anna Gasiorowska-Bien, Wiktor Niewiadomski, Charles R Harrington, Claude M Wischik, Gernot Riedel, Grazyna Niewiadomska
Neuroprotection of Cholinergic Neurons with a Tau Aggregation Inhibitor and Rivastigmine in an Alzheimer's-like Tauopathy Mouse Model. Cells 13 (7) (2024)
Maciej Zadrozny, Patrycja Drapich, Anna Gasiorowska-Bien, Wiktor Niewiadomski, Charles R Harrington, Claude M Wischik, Gernot Riedel, Grazyna Niewiadomska
Neuroprotection of Cholinergic Neurons with a Tau Aggregation Inhibitor and Rivastigmine in an Alzheimer's-like Tauopathy Mouse Model. Cells 13 (7) (2024)
Maciej Zadrozny, Patrycja Drapich, Anna Gasiorowska-Bien, Wiktor Niewiadomski, Charles R Harrington, Claude M Wischik, Gernot Riedel, Grazyna Niewiadomska
Neuroprotection of Cholinergic Neurons with a Tau Aggregation Inhibitor and Rivastigmine in an Alzheimer's-like Tauopathy Mouse Model. Cells 13 (7) (2024)
Mohammad Arastoo, Michael P Mazanetz, Sonya Miller, Helen Shiells, Claire Hull, Keith Robinson, John M D Storey, Charles R Harrington, Claude M Wischik
Exploring the Anti-Hypoxaemia Effect of Hydromethylthionine: A Prospective Study of Phase 3 Clinical Trial Participants. International journal of molecular sciences 24 (18) (2023)
Alex Zabala-Findlay, Lewis K Penny, Richard A Lofthouse, Andrew J Porter, Soumya Palliyil, Charles R Harrington, Claude M Wischik, Mohammad Arastoo
Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer's Disease: Systematic Review and Meta-Analysis. Cells 12 (8) (2023)
Alex Zabala-Findlay, Lewis K Penny, Richard A Lofthouse, Andrew J Porter, Soumya Palliyil, Charles R Harrington, Claude M Wischik, Mohammad Arastoo
Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer's Disease: Systematic Review and Meta-Analysis. Cells 12 (8) (2023)
Constantin Kondak, Michael Leith, Thomas C Baddeley, Renato X Santos, Charles R Harrington, Claude M Wischik, Gernot Riedel, Jochen Klein
Mitochondrial Effects of Hydromethylthionine, Rivastigmine and Memantine in Tau-Transgenic Mice. International journal of molecular sciences 24 (13) (2023)
Alex Zabala-Findlay, Lewis K Penny, Richard A Lofthouse, Andrew J Porter, Soumya Palliyil, Charles R Harrington, Claude M Wischik, Mohammad Arastoo
Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer's Disease: Systematic Review and Meta-Analysis. Cells 12 (8) (2023)
Renato X Santos, Valeria Melis, Elizabeth A Goatman, Michael Leith, Thomas C Baddeley, John M D Storey, Gernot Riedel, Claude M Wischik, Charles R Harrington
HMTM-Mediated Enhancement of Brain Bioenergetics in a Mouse Tauopathy Model Is Blocked by Chronic Administration of Rivastigmine. Biomedicines 10 (4) (2022)
Mahmoud Bukar Maina, Youssra K Al-Hilaly, Gunasekhar Burra, Janet E Rickard, Charles R Harrington, Claude M Wischik, Louise C Serpell
Oxidative Stress Conditions Result in Trapping of PHF-Core Tau (297-391) Intermediates. Cells 10 (3) (2021)
Luis O Soto-Rojas, B Berenice Campa-Córdoba, Charles R Harrington, Andrés Salas-Casas, Mario Hernandes-Alejandro, Ignacio Villanueva-Fierro, Marely Bravo-Muñoz, Linda Garcés-Ramírez, Fidel De La Cruz-López, Miguel Ángel Ontiveros-Torres, Goar Gevorkian, Mar Pacheco-Herrero, José Luna-Muñoz
Insoluble Vascular Amyloid Deposits Trigger Disruption of the Neurovascular Unit in Alzheimer's Disease Brains. International journal of molecular sciences 22 (7) (2021)
Karima Schwab, Valeria Melis, Charles R Harrington, Claude M Wischik, Mandy Magbagbeolu, Franz Theuring, Gernot Riedel
Proteomic Analysis of Hydromethylthionine in the Line 66 Model of Frontotemporal Dementia Demonstrates Actions on Tau-Dependent and Tau-Independent Networks. Cells 10 (8) (2021)
Vesna Vuksanović, Roger T Staff, Suzannah Morson, Trevor Ahearn, Luc Bracoud, Alison D Murray, Peter Bentham, Christopher M Kipps, Charles R Harrington, Claude M Wischik
Degeneration of basal and limbic networks is a core feature of behavioural variant frontotemporal dementia. Brain communications 3 (4) (2021)

Charles R Harrington.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Charles R Harrington